AMELIA B ZELNAK

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CUMMING, GA NPI 1679697791

General Payments — all program years on this page

$31,992.12

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 182
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $4,498.37 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $4,080.002
Food and Beverage $418.3716

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $6,665.2328
2019 $3,095.9230
2020 $3,141.2119
2021 $5,085.7730
2022 $5,222.2921
2023 $4,283.3336
2024 $4,498.3718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078533846 Janssen Biotech, Inc. $26.37 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078534456 Janssen Biotech, Inc. $30.86 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078534607 Janssen Biotech, Inc. $26.57 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087371830 Novartis Pharmaceuticals Corporation $2,025.00 02/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087371846 Novartis Pharmaceuticals Corporation $22.25 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093950791 AstraZeneca UK Limited $2,055.00 07/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101086063 Celgene Corporation $25.51 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101233579 E.R. Squibb & Sons, L.L.C. $15.90 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105220751 AstraZeneca Pharmaceuticals LP $27.24 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105591408 AstraZeneca Pharmaceuticals LP $27.96 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113850550 PUMA BIOTECHNOLOGY, INC. $20.13 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113852009 PUMA BIOTECHNOLOGY, INC. $23.11 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131313858 PFIZER INC. $21.49 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133796269 Gilead Sciences, Inc. $20.91 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133796271 Gilead Sciences, Inc. $19.22 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133796273 Gilead Sciences, Inc. $45.75 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136024336 Eli Lilly and Company $40.08 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139763102 GENZYME CORPORATION $25.02 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.